Advancing human health risk assessment: Integrating recent advisory committee recommendations

Abstract Over the last dozen years, many national and international expert groups have considered specific improvements to risk assessment. Many of their stated recommendations are mutually supportive, but others appear conflicting, at least in an initial assessment. This review identifies areas of consensus and difference and recommends a practical, biology-centric course forward, which includes: (1) incorporating a clear problem formulation at the outset of the assessment with a level of complexity that is appropriate for informing the relevant risk management decision; (2) using toxicokinetics and toxicodynamic information to develop Chemical Specific Adjustment Factors (CSAF); (3) using mode of action (MOA) information and an understanding of the relevant biology as the key, central organizing principle for the risk assessment; (4) integrating MOA information into dose–response assessments using existing guidelines for non-cancer and cancer assessments; (5) using a tiered, iterative approach developed by the World Health Organization/International Programme on Chemical Safety (WHO/IPCS) as a scientifically robust, fit-for-purpose approach for risk assessment of combined exposures (chemical mixtures); and (6) applying all of this knowledge to enable interpretation of human biomonitoring data in a risk context. While scientifically based defaults will remain important and useful when data on CSAF or MOA to refine an assessment are absent or insufficient, assessments should always strive to use these data. The use of available 21st century knowledge of biological processes, clinical findings, chemical interactions, and dose–response at the molecular, cellular, organ and organism levels will minimize the need for extrapolation and reliance on default approaches.

• Publication year

  2013

• Venue

  Critical Reviews in Toxicology

• Publication date

  2013-07-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.3109/10408444.2013.807223PMID 23844697PMCID 3725687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Carcinogenic substances].

  2020cited by this paper
• Health risk assessment of chemical mixtures

  2015cited by this paper
• Ecological Risk Assessment Guidance for Superfund: Process for Designing and Conducting Ecological Risk Assessments - Interim Final

  2015cited by this paper
• Framework for Cumulative Risk Assessment

  2014cited by this paper
• Recommendation from the Scientific Committee on Occupational Exposure Limits

  2014cited by this paper
• Guidelines for the Health Risk Assessment of Chemical Mixtures

  2014cited by this paper
• Guidance for Applying Quantitative Data to Develop Data-Derived Extrapolation Factors for Interspecies and Intraspecies Extrapolation

  2014cited by this paper
• Evaluation with uncertainty

  2014cited by this paper
• PRN 96-5: Interim Use of the Proposed Guidelines for Carcinogen Risk Assessment

  2014cited by this paper
• A framework for fit-for-purpose dose response assessment.

  2013cited by this paper
• Framework for Human Health Risk Assessment to Inform Decision Making

  2013cited by this paper
• Mandated data archiving greatly improves access to research data

  2013cited by this paper
• Microbial Risk Assessment Guideline: Pathogenic Microorganisms with Focus on Food and Water

  2013cited by this paper
• Use of Early Effect Biomarker Data to Enhance Dose-Response Models of Lung Tumors in Rats Exposed to Titanium Dioxide

  2013cited by this paper
• Quantitative approaches for assessing dose–response relationships in genetic toxicology studies

  2013cited by this paper
• The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments.

  2012influential reference
• Identification and characterization of adverse effects in 21st century toxicology.

  2012cited by this paper
• Development of Screening Tools for the Interpretation of Chemical Biomonitoring Data

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Physiologically-based pharmacokinetic (PBPK) models in toxicity testing and risk assessment.

  2012cited by this paper
• Evaluation of Biomonitoring Data from the CDC National Exposure Report in a Risk Assessment Context: Perspectives across Chemicals

  2012cited by this paper
• A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening.

  2012cited by this paper
• Approaches to Human Health Risk Assessment Based on the Signal-To-Noise Crossover Dose

  2012cited by this paper
• Integrated Molecular Analysis Indicates Undetectable Change in DNA Damage in Mice after Continuous Irradiation at ~ 400-fold Natural Background Radiation

  2012cited by this paper
• Use of NHANES Data to Link Chemical Exposures to Chronic Diseases: A Cautionary Tale

  2012cited by this paper
• Integrating pathway-based transcriptomic data into quantitative chemical risk assessment: a five chemical case study.

  2012cited by this paper
• Physiologically based pharmacokinetic model use in risk assessment--Why being published is not enough.

  2012cited by this paper
• Maximum Cumulative Ratio (MCR) as a Tool for Assessing the Value of Performing a Cumulative Risk Assessment

  2011influential reference
• A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients.

  2011cited by this paper
• Using mode of action information to improve regulatory decision-making: An ECETOC/ILSI RF/HESI workshop overview

  2011influential reference
• Health Risks from Exposure to Low Levels of Ionizing Radiation : BEIR VII Phase 2 4 / 10 / 2011

  2011cited by this paper
• Guidelines for Drinking-water Quality, Fourth Edition

  2011cited by this paper
• Role of science and judgment in setting national ambient air quality standards: how low is low enough?

  2011cited by this paper
• Predictive models of prenatal developmental toxicity from ToxCast high-throughput screening data.

  2011cited by this paper
• Environmental Chemicals in Pregnant Women in the United States: NHANES 2003–2004

  2011cited by this paper
• Endogenous versus exogenous DNA adducts: their role in carcinogenesis, epidemiology, and risk assessment.

  2011cited by this paper
• Using Nuclear Receptor Activity to Stratify Hepatocarcinogens

  2011cited by this paper
• Risk assessment of combined exposure to multiple chemicals: A WHO/IPCS framework.

  2011influential reference
• Chemical carcinogenesis.

  2011cited by this paper
• Human biomonitoring assessment values: approaches and data requirements.

  2011cited by this paper
• Development of a source-to-outcome model for dietary exposures to insecticide residues: an example using chlorpyrifos.

  2011cited by this paper
• Application of a source-to-outcome model for the assessment of health impacts from dietary exposures to insecticide residues.

  2011cited by this paper
• Predictive Model of Rat Reproductive Toxicity from ToxCast High Throughput Screening1

  2011cited by this paper
• CHARACTERIZATION AND APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS IN RISK ASSESSMENT

  2011cited by this paper
• Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification

  2011influential reference
• A Signal-to-Noise Crossover Dose as the Point of Departure for Health Risk Assessment

  2011influential reference
• Linear low-dose extrapolation for noncancer health effects is the exception, not the rule

  2011influential reference
• Cancer risk assessment : chemical carcinogenesis, hazard evaluation, and risk quantification

  2010influential reference
• Science and Decisions: Advancing Risk Assessment

  2010cited by this paper
• Miniaturized flow cytometric in vitro micronucleus assay represents an efficient tool for comprehensively characterizing genotoxicity dose-response relationships.

  2010cited by this paper
• PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals.

  2010cited by this paper
• A mechanistic redefinition of adverse effects - a key step in the toxicity testing paradigm shift.

  2010cited by this paper
• A Bayesian Network Model for Biomarker‐Based Dose Response

  2010cited by this paper
• 1,3-Butadiene: III. Assessing carcinogenic modes of action

  2010cited by this paper
• Genotoxicity testing: Moving beyond qualitative “screen and bin” approach towards characterization of dose‐response and thresholds

  2010cited by this paper
• Linear Low‐Dose Extrapolations

  2010cited by this paper
• Proposed mode of action of benzene-induced leukemia: Interpreting available data and identifying critical data gaps for risk assessment.

  2010cited by this paper
• Toxicity Testing in the 21st Century: A Vision and a Strategy

  2010cited by this paper
• The Key Events Dose-Response Framework: A Cross-Disciplinary Mode-of-Action Based Approach to Examining Dose-Response and Thresholds

  2009cited by this paper
• Toxicity testing in the 21st century: bringing the vision to life.

  2009cited by this paper
• Non-linear dose-response of DNA-reactive genotoxins: recommendations for data analysis.

  2009cited by this paper
• recommended daily allowances

  2009cited by this paper
• Toxicity testing in the 21st century: a view from the chemical industry.

  2009cited by this paper
• Application of Key Events Analysis to Chemical Carcinogens and Noncarcinogens

  2009influential reference
• Derivation of inhalation toxicity reference values for propylene oxide using mode of action analysis: Example of a threshold carcinogen

  2009cited by this paper
• Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context

  2009cited by this paper
• Dose-response and operational thresholds/NOAELs for in vitro mutagenic effects from DNA-reactive mutagens, MMS and MNU.

  2009cited by this paper
• In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU.

  2009cited by this paper
• An Adjustment Factor for Mode‐of‐Action Uncertainty with Dual‐Mode Carcinogens: The Case of Naphthalene‐Induced Nasal Tumors in Rats

  2008cited by this paper
• Recent developments in frameworks to consider human relevance of hypothesized modes of action for tumours in animals

  2008cited by this paper
• Environmental Health Criteria 240 PRINCIPLES AND METHODS FOR THE RISK ASSESSMENT OF CHEMICALS IN FOOD

  2008cited by this paper
• Applying bioethical principles to human biomonitoring

  2008influential reference
• Profiling Chemicals Based on Chronic Toxicity Results from the U.S. EPA ToxRef Database

  2008cited by this paper
• Environmental chemicals in people: challenges in interpreting biomonitoring information.

  2008cited by this paper
• Evidence-based dose-response assessment for thyroid tumorigenesis from acrylamide.

  2008cited by this paper
• Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.

  2008cited by this paper
• Public Participation in Environmental Assessment and Decision Making

  2008cited by this paper
• Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.

  2008cited by this paper
• Boron tolerable intake

  2007cited by this paper
• Development of a Screening Approach to Interpret Human Biomonitoring Data on Volatile Organic Compounds: Reverse Dosimetry on Biomonitoring Data for Trichloroethylene

  2007influential reference
• Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens.

  2007influential reference
• Will the Circle Be Unbroken: A History of the U.S. National Ambient Air Quality Standards

  2007cited by this paper
• An Approach to Risk Assessment for TiO2

  2007cited by this paper
• Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.

  2007cited by this paper
• Framework for metals risk assessment.

  2007cited by this paper
• Network motifs: theory and experimental approaches

  2007cited by this paper
• Global clinical data interchange standards are here!

  2007cited by this paper
• Development of a toxicogenomics in vitro assay for the efficient characterization of compounds.

  2006cited by this paper
• Physicochemical modelling of cell signalling pathways

  2006cited by this paper
• Dosimetric Models : Empirical Pharmacokinetics INHALATION REFERENCE DOSE ( RfDi): AN APPLICATION OF INTERSPECIES DOSIMETRY MODELING FOR RISK ASSESSMENT OF INSOLUBLE PARTICLES

  2006cited by this paper
• Principles for evaluating health risks in children associated with exposure to chemicals

  2006cited by this paper
• Reporting results of biomonitoring studies

  2006cited by this paper
• IPCS framework for analysing the relevance of a cancer mode of action for humans

  2006cited by this paper
• Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data

  2005cited by this paper
• Public Participation

  2005cited by this paper
• Lower birth weight as a critical effect of chlorpyrifos: a comparison of human and animal data.

  2005cited by this paper
• Prenatal Insecticide Exposures and Birth Weight and Length among an Urban Minority Cohort

  2004cited by this paper
• Dose-dependent transitions in mechanisms of toxicity: case studies.

  2004influential reference
• Toxicogenomics and systems toxicology: aims and prospects

  2004cited by this paper
• Dose-dependent transitions in mechanisms of toxicity.

  2004influential reference

• Mechanistic computational framework for human half-lives of 931 organic chemicals

  2026cites this paper
• Beyond key characteristics of carcinogens: an archetypal MOA-based evidence system for hypothesis testing to advance carcinogen risk assessment

  2025cites this paper
• Impact study of toxic elements from confectionery and nut products on consumers of different age groups

  2025cites this paper
• Enhancing laboratory biosafety management: a comprehensive strategy from theory to practice

  2024cites this paper
• Data derived extrapolation factors (DDEFs) for rat to human interspecies extrapolation for the HPPD inhibitor mesotrione

  2024cites this paper
• Characteristics comparison of gaseous and particle-phase VOCs released by smoldering mosquito coils and their health risks

  2023cites this paper
• Modulation of gene expression and influence of gene polymorphisms related to genotoxicity and redox status on occupational exposure to inhaled anesthetics.

  2023cites this paper
• A rapid review of best practices in the development of risk registers for public health emergency management

  2023cites this paper
• Toxicity dose descriptors from animal inhalation studies of 13 nanomaterials and their bulk and ionic counterparts and variation with primary particle characteristics

  2023cites this paper
• A Negative Feedback Loop and Transcription Factor Cooperation Regulate Zonal Gene Induction by 2, 3, 7, 8‐Tetrachlorodibenzo‐p‐Dioxin in the Mouse Liver

  2021influential citation
• Integrating toxicokinetics into toxicology studies and the human health risk assessment process for chemicals: Reduced uncertainty, better health protection.

  2021cites this paper
• Considerations for the Use of Mutation as a Regulatory Endpoint in Risk Assessment

  2020influential citation
• Extrapolation-Procedures for Carcinogenic and Noncarcinogenic Compounds

  2020cites this paper
• Radiofrequency radiation: carcinogenic and other potential risks

  2020cites this paper
• Nonanimal toxicology testing approaches for traditional and deemed tobacco products in a complex regulatory environment: Limitations, possibilities, and future directions.

  2020cites this paper
• Speciation of VOCs in the cooking fumes from five edible oils and their corresponding health risk assessments

  2019cites this paper
• CARDIOGENESIS CHANGES UNDER THE IMPACT OF CADMIUM CHLORIDE IN RAT EMBRYOGENESIS

  2019cites this paper
• Analyzing sanitation sustainability assessment frameworks for resource-limited communities.

  2019cites this paper
• Radiofrequency Electromagnetic Fields: Carcinogenic and Other Biological Effects

  2019cites this paper
• Mutation as a Toxicological Endpoint for Regulatory Decision‐Making

  2019cites this paper
• Role of PON1, SOD2, OGG1, XRCC1, and XRCC4 polymorphisms on modulation of DNA damage in workers occupationally exposed to pesticides.

  2018cites this paper
• The Epidemiological Characteristics of 131 Strains of Legionella Pneumophila

  2018cites this paper
• Base excision repair (OGG1 and XRCC1) and metabolism (PON1) gene polymorphisms act on modulation of DNA damage and immune parameters in tobacco farmers.

  2018cites this paper
• Exposure and Risk Assessment of Selected Chemical Hazards in Cabbage and Lettuce

  2018cites this paper
• Mobile phones: carcinogenic and other potential risks

  2017cites this paper
• Quantitative weight of evidence to assess confidence in potential modes of action

  2017cites this paper
• Development of an in vitro PIG-A gene mutation assay in human cells

  2017cites this paper
• How well can carcinogenicity be predicted by high throughput “characteristics of carcinogens” mechanistic data?

  2017cites this paper
• US Environmental Protection Agency's framework for human health risk assessment to inform decision making

  2017cites this paper
• Bayesian methods for uncertainty factor application for derivation of reference values.

  2016cites this paper
• Advances in assessing ingredient safety.

  2016cites this paper
• Dose and dose-rate effectiveness of radiation: first objectivity then conclusions -

  2016cites this paper
• Implementing a framework for integrating toxicokinetics into human health risk assessment for agrochemicals.

  2016cites this paper
• Assessment of inhalation exposure to indoor air pollutants: Screening for health risks of multiple pollutants in Japanese dwellings.

  2016cites this paper
• Managing risks of noncancer health effects at hazardous waste sites: A case study using the Reference Concentration (RfC) of trichloroethylene (TCE).

  2016cites this paper
• Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case study.

  2016cites this paper
• Trans fatty acids and cholesterol levels: An evidence map of the available science.

  2016cites this paper
• Computational Systems Toxicology

  2015cites this paper
• High-Content Screening: Understanding and Managing Mechanistic Data to Better Predict Toxicity

  2015cites this paper
• Proposed Approach for Cumulative Risk Assessment of Certain Phthalates under the Chemicals Management Plan

  2015cites this paper
• California biomonitoring data: Comparison to NHANES and interpretation in a risk assessment context.

  2015cites this paper
• Whither Risk Assessment: New Challenges and Opportunities a Third of a Century After the Red Book

  2015cites this paper
• Toxicological Risk Assessment for Beginners

  2015cites this paper
• Systems biology approach for evaluating the biological impact of environmental toxicants in vitro.

  2014cites this paper
• Assessment of long-term health risks after accidental exposure using haemoglobin adducts of epichlorohydrin.

  2014cites this paper
• Human Health Risk Assessment of Inhaled Materials

  2014cites this paper
• Cancer biology, toxicology and alternative methods development go hand-in-hand.

  2014cites this paper
• A 21st century roadmap for human health risk assessment

  2014cites this paper